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A Novel Nociceptor Signaling Pathway Revealed
in Protein Kinase C e Mutant Mice
several of NGF's actions, including activation of mito-
gen-activated protein (MAP) kinases Erk1 and Erk2 and
neurite outgrowth (Hundle et al., 1995, 1997). In addition,
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Jon D. Levine,* and Robert O. Messing²³ dian et al., 1995) and produces hyperalgesia (Lewin et
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Summary nociceptor function.
There is great interest in discovering new targets for
pain therapy since current methods of analgesia are Results
often only partially successful. Although protein kinase
C (PKC) enhances nociceptor function, it is not known Characterization of PKCe Mutant Mice
which PKC isozymes contribute. Here, we show that We used embryonic stem (ES) cells to generate PKCe
epinephrine-induced mechanical and thermal hyperal- mutant mice by homologous recombination (Thompson
gesia and acetic acid±associated hyperalgesia are et al., 1989). A recombination vector was constructed
markedly attenuated in PKCe mutant mice, but base- containing mouse genomic PKCe sequences harboring
line nociceptive thresholds are normal. Moreover, epi- a 1.2 kb deletion. Integration of this vector was predicted
nephrine-, carrageenan-, and nerve growth factor± (NGF-) to result in loss of the start codon (Figure 1A). This vector
induced hyperalgesia in normal rats, and epinephrine- was transfected into ES cells, and nine clones containing
induced enhancement of tetrodotoxin-resistant Na1 the homologous integration were identified. Two were
current (TTX-R INa) in cultured rat dorsal root ganglion injected into blastocysts to produce chimeric animals.
(DRG) neurons, are inhibited by a PKCe-selective in- Three chimeric males mated to C57BL/6J females trans-
hibitor peptide. Our findings indicate that PKCe regu- mitted the mutation through the germline. Heterozygous
lates nociceptor function and suggest that PKCe inhib-
progeny were intercrossed, and offspring were typed
itors could prove useful in the treatment of pain.
by Southern analysis for the PKCe mutation (Figure 1B).
Using Western blot analysis, we found that PKCe im-Introduction
munoreactivity could not be detected in dorsal root gan-
glia (DRG) (Figure 1C) or in the central nervous systemRecent evidence suggests that protein kinase C (PKC)
(data not shown) of mutant mice. All other PKC isozymesregulates nociceptor function. Tumor-promoting phor-
except PKCg could be detected in DRG from wild-typebol esters, which activate most PKC isozymes (Nishi-
mice, and their abundance was similar in wild-type andzuka, 1992), sensitize nociceptors (Schepelmann et al.,
PKCe mutant mice (Figure 1C). From 75 litters of hetero-1993) and enhance, in nociceptors, a current activated
zygous breeding pairs, 826 mice were genotyped atby a noxious thermal stimulus (Cesare and McNaughton,
weaning: 193 (23%) were wild-type, 441 (54%) were het-1996). In addition, PKC is an important contributor to
erozygotes, and 192 (23%) were homozygotes, showingdiabetic neuropathic hyperalgesia (Ahlgren and Levine,
an expected Mendelian ratio (x2 5 1.83, p 5 0.40). Food1994), bradykinin-induced activation and sensitization
and water intake were normal in mutant mice (data notof nociceptors (McGuirk and Dolphin, 1992), and epi-
shown), and body weight measured daily over 2 weeks innephrine-induced hyperalgesia and nociceptor sensiti-
8-week-old animals was similar in PKCe-mutant (24.73 6zation (Khasar et al., 1999). However, PKC is a family of
0.9 g, n 5 8) and wild-type (23.5 6 0.9 g, n 5 8) mice.at least ten serine-threonine kinases, and while there are
Locomotor activity (Figure 1D) and performance on afunctional differences between PKC isozymes (Nishizuka,
3-arm maze (data not shown) were also similar in mutant1992), it is not known which isozyme contributes to noci-
and wild-type mice, and mutants could not be distin-ceptor responses.
Recent findings suggest that PKCe may be important guished from wild-type littermates in the normal cage
in nociceptor function. PKCe is activated by nerve environment. Mutant mice have survived for over 1 year,
growth factor (NGF) (Ohmichi et al., 1993) and modulates and the spontaneous mortality rate among 500 mice of
each genotype maintained at least 6 weeks was similar
for PKCe mutant (2.6%) and wild-type (1.2%) animals³ To whom correspondence should be addressed (e-mail: romes@
itsa.ucsf.edu). (x2 5 1.28, p 5 0.26).
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Figure 1. Gene Targeting of Mouse PKCe
(A) Schematic structures of wild-type and recombinant loci, the targeting vector, and the 59 probe used for screening ES cell clones and mice.
(B) Southern blot of genomic DNA following digestion with ApaI and ScaI, showing fragments corresponding to wild-type (4.3 kb) and targeted
(1.6 kb) alleles.
(C) Western blots of DRG tissue from wild-type (1/1) and PKCe mutant (2/2) mice, using antibodies to PKC isozymes. Three immunoreactive
bands of 65, 74, and 84 kDa were detected with the anti-PKCz antibody. The 74 kDa band corresponds to what was reported for rat brain
PKCz (Hunter et al., 1995).
(D) Spontaneous locomotor activity and habituation of wild-type (white circles) and PKCe mutant (black circles) mice over 1 hr. Data are mean 6
SE values from six mice of each genotype.
PKCe Mutant Mice Show Decreased Epinephrine- a reduced thermal hyperalgesia compared with wild-
type littermates after epinephrine administration (FigureInduced and Acetic Acid±Associated Hyperalgesia
To study the role of PKCe in mechanical and thermal 2B). Finally, when evaluated by the acetic acid writhing
test (Bjorkman, 1995), mutant mice demonstrated a sig-nociceptor function, we first examined mice treated
with epinephrine. Epinephrine-induced hyperalgesia and nificantly lower nociceptive score than wild-type ani-
mals (Figure 2C).nociceptor sensitization depend on both PKC and pro-
tein kinase A (PKA) (Khasar et al., 1999). We chose to use
epinephrine rather than bradykinin, which also activates
PKC, because epinephrine acts directly on the primary A Selective Inhibitor of PKCe Decreases Epinephrine-
Induced Hyperalgesia in Ratsafferent nociceptor (Khasar et al., 1999), whereas bradyki-
nin can act indirectly (Andreev et al., 1995). We then The studies above suggest that a defect in PKCe-medi-
ated signal transduction accounts for reduced epineph-compared epinephrine-induced responses with responses
induced by prostaglandin E2 (PGE2) since PGE2-stimu- rine-induced hyperalgesia. These results were not due
to a deficit in motor function since PKCe mutant micelated sensitization is mediated only by PKA (Taiwo and
Levine, 1991). demonstrated enhanced withdrawal responses when
treated with PGE2. However, these experiments do notMechanical hyperalgesia was evaluated by von Frey
hair (VFH) stimulation. The percent withdrawal response exclude the possibility that this phenotype arises from
the absence of PKCe during development. To addressto VFH stimulation was similar in wild-type and mutant
mice (Figure 2A). However, the increase in withdrawal this issue, we examined nociceptive responses in adult
rats treated with a selective inhibitor of PKCe, so thatresponse following epinephrine injection was signifi-
cantly reduced in mutant animals. Nevertheless, mutant virtually immediate assessment of hyperalgesia follow-
ing antagonism of PKCe function could be performed.mice and their wild-type littermates showed a similar
increase in response produced by PGE2. Likewise, when In addition, we treated rats with an inhibitor of multiple
PKC isozymes to evaluate possible contributions ofthermal stimulation was employed, wild-type and mu-
tant animals demonstrated similar basal thresholds and other isozymes to nociceptor sensitization.
Upon activation, PKC isozymes translocate to specificsimilar responses to PGE2, but mutant animals displayed
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al., 1997) to selectively inhibit PKCe in peripheral nerve
terminals.
Intradermal injection of eV1±2 in normal rats de-
creased the mechanical hyperalgesia produced by in-
jection of epinephrine into the hindpaw (Figure 3A).
There was no effect from a scrambled eV1±2 peptide
(Johnson et al., 1996). The magnitude of inhibition pro-
duced by eV1±2 was similar to that produced by the
PKC inhibitor bisindoylmaleimide I, which inhibits sev-
eral PKC isozymes, including PKCe (Toullec et al., 1991).
Administration of eV1±2 had no effect on PGE2-induced
hyperalgesia. These results strongly support the conclu-
sion that absence of PKCe-mediated signaling in adult
neurons is responsible for reduced epinephrine sensitiv-
ity in PKCe mutant mice. Furthermore, since bisindoyl-
maleimide I was no more effective in inhibiting epineph-
rine hyperalgesia than the eV1±2 peptide, it is likely that
the PKCe isozyme alone is responsible for the contribu-
tion of PKC to epinephrine-induced hyperalgesia.
PKCe Inhibition Attenuates Enhancement
of Tetrodotoxin-Resistant Sodium
Current by Epinephrine
In DRG neurons, epinephrine enhances a tetrodotoxin-
resistant sodium current (TTX-R INa) (Khasar et al., 1999)
whose activity is increased by agents that act directly
on primary afferent nociceptors in vivo to produce hy-
peralgesia (Gold et al., 1996). Bisindoylmaleimide I at-Figure 2. Mechanical and Thermal Nociception and Response to
tenuates enhancement of TTX-R INa by epinephrineAcetic Acid in PKCe Mutant Mice
(Khasar et al., 1999), suggesting that this effect of epi-(A) Mechanical thresholds were measured in eight wild-type (black
bars) and eight mutant (gray bars) mice in response to VFH (4 g) nephrine is partially PKC dependent. Using whole-cell
stimulation. Responses were measured before (basal) and after in- patch-clamp analysis, we examined the role of PKCe in
traplantar injection of 100 ng epinephrine (Epi) or PGE2. Asterisk, epinephrine sensitization of TTX-R INa in cultured rat DRG
p , 0.001 (ANOVA and Scheffe F test).
neurons. Epinephrine enhanced TTX-R INa by z2-fold(B) Thermal nociceptive thresholds in eight wild-type (black bars)
in neurons perfused with the inactive scrambled eV1±2and eight mutant (gray bars) mice before and after intraplantar injec-
peptide (Figure 3B). Intracellular perfusion of eV1±2 pep-tion of 100 ng epinephrine (Epi) or PGE2. Asterisk, p , 0.001 (ANOVA
and Scheffe F test). tide reduced this effect of epinephrine by approximately
(C) Writhing response to acetic acid administration in four wild-type half. These results are consistent with our behavioral
(1/1) and four mutant (2/2) mice. Asterisk, p , 0.05 (Student's data (Figure 3A) and demonstrate a direct, PKCe-depen-
unpaired t test).
dent action of epinephrine on TTX-R INa in primary affer-
ent neurons.
intracellular sites, where they appear to bind to anchor-
ing proteins termed RACKs (Mochly-Rosen, 1995). The
PKCe Inhibition Reduces Carrageenan-cotamer protein b9COP has recently been identified
Mediated Hyperalgesiaas a specific RACK for PKCe (Csukai et al., 1997).
In addition to showing less epinephrine-induced hyper-PKCe binds b9COP through its V1 region, and peptides
algesia, PKCe mutant mice were less responsive thanderived from this region selectively inhibit phorbol ester±
wild-type mice in the acetic acid writhing test. Since themediated translocation of PKCe in cultured cardiac myo-
response to acetic acid is reduced by nonsteroidalcytes (Johnson et al., 1996; Gray et al., 1997), PC12
anti-inflammatory drugs (Jett et al., 1999), these resultscells (Hundle et al., 1997), and pancreatic beta cells
suggest that PKCe may be involved in inflammatory hy-(Yedovitzky et al., 1997). This inhibition of binding de-
peralgesia. To investigate this possibility further, we ex-creases phorbol ester- and norepinephrine-mediated in-
amined rats treated with intradermal injection of thehibition of contraction in cardiac myocytes (Johnson et
potent inflammatory agent carrageenan (Ferreira et al.,al., 1996) and inhibits protection of cardiac myocytes
1988). Carrageenan-evoked mechanical hyperalgesiafrom hypoxia-induced cell death (Gray et al., 1997). It
was maximal 3 hr after injection into the hindpaw (Figurealso reduces glucose-stimulated insulin secretion from
3C). Intradermal injection of eV1±2, 3.5 hr after adminis-islet cells (Yedovitzky et al., 1997) and prevents en-
tration of carrageenan, almost completely reversed thishancement of NGF-induced neurite outgrowth and MAP
response. There was no effect from the scrambled eV1±2kinase activation by phorbol esters in PC12 cells (Hundle
peptide. These results indicate that PKCe contributeset al., 1997). We used such an inhibitory peptide, eV1±2
(Johnson et al., 1996; Gray et al., 1997; Yedovitzky et to inflammatory hyperalgesia.
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Figure 3. PKC Inhibitors Attenuate Epineph-
rine- and Carrageenan-Induced Mechanical
Hyperalgesia and Epinephrine-Induced En-
hancement of TTX-R INa
(A) Rats were treated intradermally with 100
ng epinephrine (Epi) or PGE2 with or without
local injection of either 1 mg bisindoylmalei-
mide I (BIM) or sterile water followed by 1 mg
of eV1±2 peptide (eV1±2; EAVSLKPT) or 1 mg
of scrambled eV1±2 peptide (Scr; LSETKPAV).
The mean 6 SE baseline threshold before
drug treatment in the group receiving epi-
nephrine was 105.3 6 2.8 g (n 5 8). Data
are expressed as the percent change from
baseline and are mean 1 SE values from eight
(epinephrine) and ten (PGE2) experiments. As-
terisk, p , 0.001 (ANOVA and Scheffe F test).
(B) TTX-R INa was measured in cells intracellu-
larly perfused through the patch-clamp elec-
trode with 200 mM eV1±2 (black circles, n 5
4) or 200 mM scrambled eV1±2 (white circles,
n 5 4) for 15 min prior to application of 1 mM
epinephrine. There was a significant de-
crease in the effect of epinephrine in cells
treated with eV1±2 peptide (p 5 0.04 [two-
way repeated measures ANOVA]).
(C) Rats were treated intradermally with 1%
carrageenan (10 ml per paw) and tested for
mechanical hyperalgesia 3 (Car-3, n 5 12)
or 4 (Car-4, n 5 24) hr later. Some animals
received a local injection of 1 mg eV1±2 (Car 1
eV1±2, n 5 6) or scrambled eV1±2 (Car 1 Scr,
n 5 6) 3.5 hr after carrageenan administration
and were tested 30 min later. Asterisk, p ,
0.0001 (ANOVA and Scheffe F test).
NGF-Induced Hyperalgesia Is Not Reduced peripheral processes of sensory neurons was supported
by the observation of PKCe immunoreactivity in hindpawby PKCe Inhibition
In PC12 cells, NGF-induced neurite outgrowth and MAP skin from normal rats at the dermal±epidermal junction
(Figure 4A), where the highest density of afferents in thekinase activation are enhanced by overexpression of
PKCe (Hundle et al., 1995). However, downregulation skin is located (McCarthy et al., 1995; Petruska et al.,
1997). Under higher magnification, PKCe immunoreac-(Roivainen et al., 1993) or inhibition (Hundle et al., 1997)
of PKCe does not impair responses to NGF. These re- tivity in this region was observed in profiles resembling
nerve fibers (Figure 4A, insert). In addition, PKCe immu-sults indicate that PKCe modulates but is not required
for NGF signaling in PC12 cells. To investigate whether noreactivity was found in most small and some medium
diameter DRG neurons in wild-type adult mice and ratsPKCe is necessary for NGF-induced nociception, we
examined rats treated with intradermal injection of NGF. (Figures 4C, 4D, and 4G). In wild-type mice, 75% 6 4%
of all DRG neurons and 93% 6 15% of small neuronsRats were injected with 1 mg of either eV1±2 or scram-
bled eV1±2 peptide in the dorsal aspect of the hindpaw. (soma area, ,570 mm2) (Scroggs et al., 1994) expressed
PKCe immunoreactivity. Minimal background immuno-After 15 min, all rats received an injection of 1 mg of
NGF at the same site in the paw. Repeat doses of each staining was seen in DRG of PKCe mutant mice (Figure
4E). PKCe immunoreactivity was also present in thepeptide were administered 3 and 5.75 hr after NGF injec-
tion. Rats were then tested for mechanical hyperalgesia soma and process of cultured DRG neurons that express
substance P (Figures 4H and 4I). Therefore, PKCe is6 hr after receiving NGF. NGF decreased the nociceptive
threshold by 38.3% 6 3.6% (n 5 6) in rats injected with present in most DRG neurons and in fibers in the skin,
as well as in cell bodies and processes of cultured noci-the inactive scrambled eV1±2 peptide. In rats treated
with the eV1±2 peptide, NGF was less effective, decreas- ceptors.
ing the nociceptive threshold by only 29.9% 6 3.6%
(n 5 6, p 5 0.04, Student's t test). These results indicate
that PKCe also contributes to NGF-mediated hyperal- Discussion
gesia.
For more than a decade, PKC has been suggested to
play a role in nociceptive signaling. We now demonstratePKCe Expression in DRG Neurons
Since peripheral injection of eV1±2 reduced epinephrine-, the necessary contribution of a specific isozyme of PKC
to primary afferent nociceptor function. We found thatcarrageenan-, and NGF-induced hyperalgesia, we hy-
pothesized that PKCe in the peripheral terminals of DRG PKCe is required for full expression of epinephrine-
induced sensitivity to mechanical and thermal stimuli.neurons mediates this effect. That PKCe is present in the
PKCe-Dependent Regulation of Nociceptors
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Figure 4. PKCe Immunoreactivity in Skin and DRG
Skin from normal rats was incubated with PKCe antibody in the absence (A) or presence (B) of PKCe antigen peptide. No immunoreactivity
was seen when antigen was included in the incubation. PKCe-specific immunoreactivity was seen at the dermal±epidermal junction (arrowhead)
and in the dermis, with characteristics of nerve fiber staining (inset, arrows). No staining was seen in the epidermis, possibly due to limited
sensitivity of the primary antibody or because PKCe may be expressed in a subset of nociceptors that does not extend terminals into the
epidermis. Representative sections are shown from normal rat (C), wild-type mouse (D), and PKCe mutant mouse (E) DRG cells stained with
PKCe antibody. In (F), wild-type mouse DRG cells stained with secondary antibody alone. (G) shows size±frequency histogram of PKCe-
expressing (black bars) and all (gray bars) neurons from seven wild-type mouse DRG. DRG neurons from rat (H) and mouse (I) were cultured
for 7 hr in 25 ng/ml NGF and stained with antibody to substance P (red) and PKCe (green). Yellow color indicates colocalization of both
immunoreactivities. No immunostaining was observed in cells incubated with secondary antibodies alone. Scale bar, 50 mm (A±F, H, and I)
and 100 mm (inset, [A]). Abbreviations: Ep, epidermis; and De, dermis.
Because the magnitude of epinephrine-induced hyper- inflammatory hyperalgesia. For example, carrageenan-
induced inflammation increases epinephrine levels (Mik-algesia was similar in rats treated with a nonselective
PKC inhibitor and with the PKCe inhibitor peptide, PKCe hailov and Rusanova, 1993), and b-adrenergic antago-
nists reduce carrageenan-induced hyperalgesia (Cunhamay be the only PKC isozyme mediating epinephrine-
induced hyperalgesia. The presence of normal PGE2- et al., 1991). Together with our data, these findings sug-
gest that in nociceptors, PKCe participates in a b-adren-mediated responses in PKCe mutant mice is also consis-
tent with our recent data indicating that PGE2 hyperalgesia ergic receptor±stimulated pathway that contributes to
inflammatory hyperalgesia.and sensitization are not dependent on PKC but require
PKA (Khasar et al., 1999). Epinephrine, like PGE2, en- The rationale for the present study was in part our
observation that PKCe modulates NGF responses inhances TTX-R INa, which is important in nociceptor sensi-
tization and in hyperalgesia induced by inflammation PC12 cells (Hundle et al., 1995, 1997). While NGF is
known to induce hyperalgesia (Lewin and Mendell, 1993;(Khasar et al., 1999). The eV1±2 peptide reduced the
effect of epinephrine on TTX-R INa, indicating that TTX-R Woolf et al., 1994), the mechanisms involved are not
known. Therefore, we tested the hypothesis that NGF-INa is a target of PKCe as well as PKA. Taken together, our
findings suggest that PKCe contributes to epinephrine- induced hyperalgesia is mediated by PKCe. We found
that inhibition of PKCe with the eV1±2 peptide decreasedinduced hyperalgesia by enhancing TTX-R INa in primary
afferent nociceptors. NGF-induced mechanical hyperalgesia in rats. Thus,
these data provide the first evidence for a signal trans-Our findings also indicate that PKCe is required for
full expression of carrageenan-induced hyperalgesia. duction pathway that underlies NGF-induced hyperal-
gesia.This suggests a role for PKCe in pain due to inflammation
and is consistent with evidence linking epinephrine to The finding that PKCe immunoreactivity was present
Neuron
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Farese, personal communication), not 129/SvTer, as originally re-in over 90% of small diameter DRG neurons in wild-type
ported (Meiner et al., 1996). Clones were selected by culture in themice indicates that PKCe is expressed in nociceptors.
presence of G418 (180 mg/ml) and 1-(29-deoxy-29-fluoro-b-D-ara-Nevertheless, since PKCe is widely expressed in the
binofuranosyl)-5-iodouracil (200 nM). Genomic DNA isolated from 400
central nervous system (Saito et al., 1993), where it could colonies was digested with ApaI and ScaI restriction enzymes, South-
contribute to the development of hyperalgesia, our find- ern blotted, and hybridized with a 0.5 kb DNA probe 59 of the flanking
region in JD825. Nine clones were identified that contained the pre-ings do not eliminate the possibility that PKCe acts by
dicted homologous integration. Two were microinjected into embry-central mechanisms. However, since PGE2-induced hy-
onic day 3.5 C57BL/6J blastocysts. Male chimeras with 80%±90%peralgesia was normal despite attenuation of epineph-
agouti coat color were mated with C57BL/6J females, and germlinerine- and inflammation-induced hyperalgesia, it is un-
transmission was documented by Southern analysis. Breeding was
likely that our findings reflect a change in central accomplished using mixed pairs of 10±15 heterozygous hybrid male
mechanisms in PKCe mutant mice. Furthermore, periph- and female mice. Experiments were performed with wild-type and
homozygous mutant littermates.eral intradermal injection of eV1±2 peptide was sufficient
to reduce epinephrine-induced hyperalgesia in rats.
Recent evidence suggests that another PKC isozyme, Western Analysis, Immunohistochemistry,
and ImmunofluorescencePKCg, is also involved in inflammatory hyperalgesia. In
PKC isozymes were detected in freshly isolated DRG by WesternPKCg null mice, pain responses, tissue swelling, and
analysis (Hundle et al., 1997) with polyclonal anti-PKC antibodiesplasma extravasation are attenuated during the second
(0.5 mg/ml) from Santa Cruz Biotechnology (Santa Cruz, CA). Some
phase of the formalin test (Malmberg et al., 1997). Since DRG were dissected and cultured as described (Khasar et al., 1999)
this phase of the response to formalin appears to be and then enriched for neurons and plated onto poly-DL-ornithine
and laminin-coated 8-well chamber slides (Nunc, Naperville, IL) indriven by inflammation, these findings suggest that loss
medium containing 25 ng/ml NGF (Lindsay, 1988). After 7 hr in cul-of PKCg attenuates pain due to tissue injury. Unlike
ture, cells were rinsed once in ice-cold phosphate-buffered salinePKCe, PKCg cannot act by modulating signal transduc-
(PBS) (137 mM NaCl, 2.7 mM KCl, 1.47 mM KH2PO4, 8 mM Na2HPO4,tion in primary afferent nociceptors since it is not ex-
0.5 mM MgCl2, and 0.9 mM CaCl2 [pH 7.2]) and fixed in 2% parafor-pressed in those neurons. However, PKCg immunoreac- maldehyde in PBS for 15 min at 48C. Cells were incubated first in
tivity is present in lamina II of the spinal cord dorsal blocking buffer (PBS, 1% BSA, and 0.05% Triton X-100) for 1 hr at
258C and then in the same buffer containing rabbit anti-PKCe anti-horn (Malmberg et al., 1997), suggesting that it could
body (0.33 mg/ml; Santa Cruz Biotechnology, Santa Cruz, CA) andmodulate pain via spinal mechanisms. Therefore, it ap-
guinea pig anti-substance P antibody (1:400 dilution; Accuratepears that at least two members of the PKC family modu-
Chemical, Westbury, NY) overnight at 48C. Cultures were then incu-late pain responses, but they do so at different levels
bated at 258C for 1 hr in buffer containing FITC-conjugated goat
of the neuraxis. anti-rabbit immunoglobulin G (IgG) and Texas Red±conjugated goat
Local administration of epinephrine exacerbates anti-guinea pig IgG (Vector Laboratories, Burlingame, CA), both at
a 1:500 dilution. Wells were rinsed three times in PBS, coverslipssymptoms in patients with neuropathic pain (Choi and
were mounted with Vectashield (Vector Laboratories, Burlingame,Rowbotham, 1997). Therefore, our findings suggest that
CA), and immunofluorescence was observed with a Leitz DMRDepinephrine-induced activation of PKCe may be clini-
microscope (Leica, Wetzlar, Germany).cally important. Lower scores obtained in the acetic
For tissue sections, anesthetized mice and rats were trans-
acid writhing test in PKCe mutant mice and blockade cardially perfused with PBS, and then 4% paraformaldehyde in PBS.
of carrageenan-induced hyperalgesia by a specific in- Skin and DRGs were removed and placed in 4% paraformaldehyde
for 3 hr, and then in PBS containing 20% sucrose for 24 hr and 40%hibitor of PKCe in rats also suggest that PKCe contrib-
sucrose for 24 hr. Sections (5±10 mm) were cut with a refrigeratedutes to inflammatory pain. Finally, since PKCe does not
microtome (Leica; SM2000R) and stored at 2208C. DRG sectionscontribute to baseline nociceptive thresholds, and PKCe
were treated with methanol:acetone (1:1) for 10 min at 2208C, incu-mutant mice appear normal, it may be possible to de-
bated at 258C in PBS, 1% normal goat serum, and 0.05% Tween
velop PKCe inhibitors that ameliorate pathologic pain 20 for 1 hr, and then incubated in the same buffer containing anti-
without producing serious systemic side effects or in- PKCe (0.33 mg/ml) for 1±2 hr. Sections were visualized with FITC-
conjugated goat anti-rabbit IgG. The size of cell bodies was calcu-terfering with normal nociceptive responses.
lated by tracing profiles containing nuclei from digitized photo-
graphs of DRG sections with the program NIH Image 1.61. Cells
were scored as expressing PKCe immunoreactivity if the intensityExperimental Procedures
of immunostaining exceeded background levels observed in DRG
specimens from PKCe mutant mice. Skin sections were pretreatedGeneration of PKCe Mutant Mice
with 3% H2O2 before incubation with 5% normal goat serum andPKCe was cloned from a lambda FIX II 129 mouse liver genomic
0.05% Tween 20 in Superblock (Pierce, Rockford, IL). Specimenslibrary (Stratagene; 946308) with an 813 bp probe (nucleotides 470±
were then incubated with anti-PKCe antibody (0.2 mg/ml) overnight1282) from mouse PKCe cDNA (Schaap et al., 1989). The exon con-
in PBS, 1% normal goat serum, and 0.05% Tween 20, and immuno-taining the ATG start codon and encoding amino acids 1±116 of
reactivity was detected, using the ABC kit (Vector) with diamino-mouse PKCe (Schaap et al., 1989) was identified. The homologous
benzamine followed by enhancement with 0.02% osmium tetroxide.recombination vector JD825 was constructed with the vector pNTK,
obtained from Dr. R. M. Mortensen (Harvard University). A 1.0 kb
BssHII fragment (beginning 60 bp 59 from the ATG start codon) was Behavioral Tests
Animal care and handling procedures were in accordance with Uni-cloned into the BamHI site of pNTK between the neo and TK selec-
tion markers. A 6.1 kb StuI fragment downstream of the exon was versity of California, San Francisco and National Institutes of Health
guidelines. All behavioral testing was done between 10 am and 4then cloned into the HindIII site of the pNTK construct, adjacent to
the neo marker. This construct was designed to delete a 1.2 kb pm. Sprague-Dawley rats (200±250 g) were obtained from Bantin-
Kingman, Fremont, CA. Peptides were administered to rats by intra-fragment of the pkce gene, including the exon containing the transla-
tion initiation codon. The completed construct was linearized with dermal injection into the dorsal aspect of the hindpaw following
injection of sterile water, which was used to provide hypotonic shockClaI and transfected by electroporation using a Biorad gene pulsar
at 250 V and 500 mF into 129/RF8 ES cells. Recent genotyping of and to allow entry of the peptides into cells (Keeney and Linn, 1990;
Lepers et al., 1990; Schulz, 1990).RF8 cells indicates that they are isogenic with 129/SvJae lines (R.
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For mechanical nociceptive testing in rats, the nociceptive flexion activation on post-herpetic neuralgia pain and sensory distur-
bances. Pain 69, 55±63.reflex was quantified with an Ugo Basile analgesymeter (Stoelting,
Chicago, IL) (Aley and Levine, 1997a, 1997b). Baseline mechanical Csukai, M., Cehn, C.-H., De Matteis, M.A., and Mochly-Rosen, D.
thresholds were determined before drug treatment and then in three (1997). Cotamer protein b9-COP, a selective binding protein (RACK)
trials performed 15, 20, and 25 min after administration of a hyperal- for epsilon protein kinase C. J. Biol. Chem. 272, 29200±29206.
gesic agent. The paw withdrawal threshold was calculated as the Cunha, F.Q., Lorenzetti, B.B., Poole, S., and Ferreira, S.H. (1991).
mean of these three readings. Interleukin-8 as a mediator of sympathetic pain. Br. J. Pharmacol.
Mechanical nociceptive thresholds in mice were measured as the 104, 765±767.
withdrawal response frequency to five applications of a 4 g VFH
Ferreira, S.H., Lorenzetti, B.B., Bristow, A.F., and Poole, S. (1988).(Stoelting, Chicago), before and after intraplantar injection of the
Interleukin-1 beta as a potent hyperalgesic agent antagonized by atest agent (Kinnman and Levine, 1995). Thermal thresholds in mice
tripeptide analogue. Nature 334, 698±700.were determined by the Hargreave test (Aley et al., 1996), and chemi-
Gold, M.S., Reichling, D.B., Shuster, M.J., and Levine, J.D. (1996).cal nociception in mice was determined by the acetic acid writhing
Hyperalgesic agents increase a tetrodotoxin-resistant Na1 currenttest (Ward and Takemori, 1983).
in nociceptors. Proc. Natl. Acad. Sci. USA 93, 1108±1112.Spontaneous locomotor activity in mice was measured in 17 3
Gray, M.O., Karliner, J.S., and Mochly-Rosen, D. (1997). A selective17 inch Plexiglas chambers located in sound-attenuating cubicles
epsilon±protein kinase C antagonist inhibits protection of cardiacand equipped with two sets of 16 pulse-modulated infrared pho-
myocytes from hypoxia-induced cell death. J. Biol. Chem. 272,tobeams to record X±Y ambulatory movements at a 100 ms resolu-
30945±30951.tion (Med Associates, Lafayette, IN). Mice were handled and
weighed daily for 1 week prior to activity testing. On the test day, Hundle, B., McMahon, T., Dadgar, J., and Messing, R.O. (1995).
mice were weighed and placed immediately in the activity chambers. Overexpression of e-protein kinase C enhances nerve growth factor±
Horizontal distance traveled (cm) was recorded for 1 hr. induced phosphorylation of mitogen-activated protein kinases and
neurite outgrowth. J. Biol. Chem. 270, 30134±30140.
Cell Culture and Electrophysiology Hundle, B., McMahon, T., Dadgar, J., Chen, C.-H., Mochly-Rosen,
Primary cultures of adult rat lumbar DRGs were prepared, and TTX-R INa D., and Messing, R.O. (1997). An inhibitory fragment derived from
was examined by whole-cell voltage-clamp recording as described protein kinase C e prevents enhancement of nerve growth factor
responses by ethanol and phorbol esters. J. Biol. Chem. 272, 15028±previously (Khasar et al., 1999). The eV1±2 and scrambled eV1±2
15035.peptides were intracellularly perfused from the electrode for 15 min
prior to bath application of 1 mM epinephrine. Throughout each Hunter, S.E., Seibenhener, M.L., and Wooten, M.W. (1995). Atypical
experiment, the amplitude of the peak inward current was normal- z-protein kinase C displays a unique developmental expression pat-
ized to the average current measured during the 3 min prior to tern in rat brain. Dev. Brain 85, 239±248.
application of epinephrine. The time course of changes in the mean Jett, M.F., Ramesha, C.S., Brown, C.D., Chiu, S., Emmett, C., Voro-
normalized current 6 SE was plotted with data binned into 1 min nin, T., Sun, T., O'Yang, C., Hunter, J.C., Eglen, R.M., and Johnson,
intervals. R.M. (1999). Characterization of the analgesic and anti-inflammatory
activities of ketorolac and its enantiomers in the rat. J. Pharmacol.
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